Quadri-lineage disease involving nodal B-cell marginal zone lymphoma, high-grade B-cell lymphoma, Kaposi's syndrome, and acute myeloid leukemia

Clinical Case Reports
Kamel LaribiDelphine Bolle

Abstract

A patient with a marginal zone lymphoma received RCHOP and obtained PR. He received RDHAP, autograft, and obtained CR. Three months later, he developed Kaposi's sarcoma with spontaneous regression. Two months later, he developed DLBCL treated with R-MIV with CR. Thereafter, he developed AML and died a few days later.

References

Apr 1, 1991·Cancer·L B TravisJ F Fraumeni
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J O Armitage, D D Weisenburger
Oct 3, 1999·Current Opinion in Oncology·P McLaughlin
May 27, 2003·The American Journal of Surgical Pathology·Francisca I CamachoMiguel A Piris
May 6, 2004·Blood·Philippe Solal-CélignyEmili Montserrat
Mar 8, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nadejda Y MudieDavid C Linch
Apr 18, 2006·Current Treatment Options in Oncology·Catherine Thieblemont, Bertrand Coiffier
Jan 20, 2007·British Journal of Haematology·Luca ArcainiUNKNOWN Intergruppo Italiano Linfomi
Feb 12, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M PiraniS Sacchi
Sep 6, 2013·Leukemia & Lymphoma·Maria K AngelopoulouTheodoros P Vassilakopoulos
Dec 21, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A H MeyerC W Scholz

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
PCR
biopsies

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

© 2022 Meta ULC. All rights reserved